期刊文献+

中医辨证配合西药治疗早期糖尿病肾病临床观察 被引量:4

TCM with Western Medicine Treatment of Early Diabetic Nephropathy
下载PDF
导出
摘要 目的:观察补肾益元汤配合西药治疗早期糖尿病肾病的临床疗效。方法:将60例随机分为两组,在常规控制饮食、血糖、血压的基础上,对照组给予福欣普利口服治疗,治疗组在对照组的基础上给予补肾益元汤,观察3个月。结果:对照组总有效率56.67%,治疗组总有效率83.33%,两组比较差异显著(P<0.05)。福欣普利与补肾益元汤合用有明显升高糖尿病肾病患者血浆白蛋白和降低尿蛋白的作用,补肾益元汤还有降低血胆固醇和甘油三酯等作用,福欣普利则无此作用,二者合用对糖尿病肾病患者的血肌酐还有降低作用。结论:补肾益元汤通过升高糖尿病肾病患者血浆白蛋白和降低尿蛋白的作用以及降低血脂、血肌酐减轻肾小球的损害,延缓肾功能的减退,提高了糖尿病肾病患者的临床有效率。 Objective:To observe the Bushen Yuan Tang in Treating the clinical efficacy of early diabetic nephropathy.Methods:60 cases were randomly divided into two groups,in the conventional control diet,blood sugar,blood pressure,based on the control group was given Fuxinpuli oral treatment,the treatment group in the control group on the basis of granting Bushen Yuan Tang,observation 3 months.Results:In control group,the total efficiency of 56.67%,treatment group,the total efficiency of 83.33%,a significant difference between the two groups (P〈0.05).Fuxinpuli combination with Bushen Motoyu significantly elevated in patients with diabetic nephropathy reduces urinary protein,plasma albumin and the role of Bushen Yuan Tang also lower blood cholesterol and triglycerides such as the role of Fuxinpuli then there is no such effect,the two combined in patients with diabetic nephropathy have reduced the role of serum creatinine.Conclusion:Bushen Motoyu by raising plasma albumin in patients with diabetic nephropathy and reduce the role of urine protein and lower blood lipids,serum creatinine reduce glomerular damage,delay decreased renal function improved in patients with diabetic nephropathy and efficient clinical.
机构地区 丽水市人民医院
出处 《中华中医药学刊》 CAS 2010年第5期1105-1107,共3页 Chinese Archives of Traditional Chinese Medicine
关键词 补肾益元汤 糖尿病肾病 中医药疗法 临床观察 Bushenyuan Tang diabetic nephropathy TCM therapy clinical observation
  • 相关文献

参考文献9

二级参考文献43

  • 1李恩民,许丽艳,齐辛,李琳,杨同书,付春艳,李善日.分光光度法检测血清中NO含量[J].白求恩医科大学学报,1996,22(1):103-104. 被引量:13
  • 2庞战军,陈瑗,周玫.活性氧、一氧化氮与氧化型低密度脂蛋白[J].中国动脉硬化杂志,1996,4(4):300-303. 被引量:3
  • 3梁进权,王宁生.调血脂及抗动脉粥样硬化中药药效方法学研究[J].中药新药与临床药理,1996,7(4):23-23. 被引量:1
  • 4熊燕,李元建.一氧化氮与动脉粥样硬化[J].中国药理学通报,1996,12(5):389-391. 被引量:8
  • 5Mogensen CE. Microalbuminuria predicts clinical proteinuria and early mortality in maturity onset diabetes. N Engl J Med, 1984,310: 356-360.
  • 6Remuzzi G, Bertani T. Pathophysiology of progressive nephropathies. N Engl J Med,1998,339:1 448
  • 7Remuzzi G, Ruggenenti P, Benigni A. Understanding the nature of renal disease progression. Kidney Int, 1997,51:2
  • 8Ruggenenti P, Perna A, Mosconi L et al. Urinary protein excretion rate is the best independent predictor of ESRF in non-diabetic proteinuric chronic nephropathies. Kidney Int, 1998,53:1 209
  • 9Jafar TH, Stark PC, Schmid CH et al. Proteinuria as a modifiable risk factor for the progression of non-diabetic renal diseases. Kidney Int,2001,60:1 131
  • 10Burton C, Harris KP. The role of proteinuria in the progression of chronic renal failure. Am J Kidney Dis,1996,27:765

共引文献544

同被引文献69

引证文献4

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部